Johnson & Johnson Q3 2024 10-Q Filing
Ticker: JNJ · Form: 10-Q · Filed: 2024-10-23T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, debt, healthcare
Related Tickers: JNJ
TL;DR
JNJ Q3 2024 10-Q filed. Financials and debt details out.
AI Summary
Johnson & Johnson filed its 10-Q for the period ending September 29, 2024. The filing details financial performance and operational updates for the third quarter of 2024. Key financial data and disclosures related to the company's business segments and outstanding debt are presented.
Why It Matters
This filing provides investors with a detailed look at Johnson & Johnson's financial health and operational performance during the third quarter of 2024, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.
Key Numbers
- 2024-09-29 — Fiscal Period End (This is the end date for the reporting period covered by the 10-Q.)
- 2024-10-23 — Filing Date (This is the date the 10-Q was officially filed with the SEC.)
- 12/29 — Fiscal Year End (Indicates the end of Johnson & Johnson's fiscal year.)
Key Players & Entities
- JOHNSON & JOHNSON (company) — Filer
- 0000200406 (company) — Central Index Key
- 20240929 (date) — Period of Report
- 20241023 (date) — Filing Date
- 2834 (other) — Standard Industrial Classification (Pharmaceutical Preparations)
FAQ
What is the total revenue for the nine months ended September 29, 2024?
The filing does not explicitly state the total revenue for the nine months ended September 29, 2024, but it provides details on financial performance for the period.
What are the key debt instruments mentioned in the filing?
The filing mentions several debt instruments including A5.50 Notes Due 2024, A1.150 Notes Due November 2028, A3.20 Notes Due November 2032, A1.650 Notes Due 2035, A3.350 Notes Due November 2036, and A3.550 Notes Due November 2044.
What is the company's Standard Industrial Classification code?
Johnson & Johnson's Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
What is the state of incorporation for Johnson & Johnson?
Johnson & Johnson is incorporated in New Jersey (NJ).
What is the filing date of this 10-Q report?
This 10-Q report was filed on October 23, 2024.
From the Filing
0000200406-24-000096.txt : 20241023 0000200406-24-000096.hdr.sgml : 20241023 20241023160227 ACCESSION NUMBER: 0000200406-24-000096 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 99 CONFORMED PERIOD OF REPORT: 20240929 FILED AS OF DATE: 20241023 DATE AS OF CHANGE: 20241023 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1229 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 241389214 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 10-Q 1 jnj-20240929.htm 10-Q jnj-20240929 0000200406 12/29 2024 Q3 FALSE xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure iso4217:EUR jnj:segment jnj:entity jnj:claimant jnj:claim jnj:cases 0000200406 2024-01-01 2024-09-29 0000200406 us-gaap:CommonStockMember 2024-01-01 2024-09-29 0000200406 jnj:A5.50NotesDue2024Member 2024-01-01 2024-09-29 0000200406 jnj:A1.150NotesDueNovember2028Member 2024-01-01 2024-09-29 0000200406 jnj:A3.20NotesDueNovember2032Member 2024-01-01 2024-09-29 0000200406 jnj:A1.650NotesDue2035Member 2024-01-01 2024-09-29 0000200406 jnj:A3.350NotesDueNovember2036Member 2024-01-01 2024-09-29 0000200406 jnj:A3.550NotesDueNovember2044Member 2024-01-01 2024-09-29 0000200406 2024-10-16 0000200406 2024-09-29 0000200406 2023-12-31 0000200406 2024-07-01 2024-09-29 0000200406 2023-07-03 2023-10-01 0000200406 2023-01-02 2023-10-01 0000200406 2024-06-30 0000200406 us-gaap:RetainedEarningsMember 2024-06-30 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0000200406 us-gaap:CommonStockMember 2024-06-30 0000200406 us-gaap:TreasuryStockCommonMember 2024-06-30 0000200406 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-29 0000200406 us-gaap:TreasuryStockCommonMember 2024-07-01 2024-09-29 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-29 0000200406 us-gaap:RetainedEarningsMember 2024-09-29 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-29 0000200406 us-gaap:CommonStockMember 2024-09-29 0000200406 us-gaap:TreasuryStockCommonMember 2024-09-29 0000200406 us-gaap:RetainedEarningsMember 2023-12-31 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000200406 us-gaap:CommonStockMember 2023-12-31 0000200406 us-gaap:TreasuryStockCommonMember 2023-12-31 0000200406 us-gaap:RetainedEarningsMember 2024-01-01 2024-09-29 0000200406 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-09-29 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-09-29 0000200406 2023-07-02 0000200406 us-gaap:RetainedEarningsMember 2023-07-02 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-02 0000200406 us-gaap:CommonStockMember 2023-07-02 0000200406 us-gaap:TreasuryStockCommonMember 2023-07-02 0000200406 us-gaap:NoncontrollingInterestMember 2023-07-02 0000200406 us-gaap:RetainedEarningsMember 2023-07-03 2023-10-01 0000200406 us-gaap:TreasuryStockCommonMember 2023-07-03 2023-10-01 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-03 2023-10-01 0000200406 us-gaap:NoncontrollingInterestMember 2023-07-03 2023-10-01 0000200406 2023-10-01 0000200406 us-gaap:RetainedEarningsMember 2023-10-01 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-10-01 0000200406 us-gaap:CommonStockMember 2023-10-01 0000200406 us-gaap:TreasuryStockCommonMember 2023-10-01 0000200406 us-gaap:NoncontrollingInterestMember 2023-10-01 0000200406 2023-01-01 0000200406 us-gaap:RetainedEarningsMember 2023-01-01 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 0000200406 us-gaap:CommonStockMember 2023-01-01 0000200406 us-gaap:TreasuryStockCommo